The use of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a mouthwash in patients with chemotherapy-induced oral mucositis

International Review of Allergology and Clinical Immunology

Volumn 9, Issue 1, 2003, Pages 14-16

  Papila, Çiǧdem ^a   Papila, Irfan ^a   Yanardaǧ, Halil ^a,b   Cansiz, Harun ^a   Çaǧatay, Pembe ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Antineoplastic agents; Granulocyte macrophage colony stimulating factor; Mouth mucosa; Moutwashes

Indexed keywords

ANTINEOPLASTIC AGENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NYSTATIN;

ADULT; AGED; ARTICLE; CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FISHER EXACT TEST; HUMAN; IMMUNOTHERAPY; MALE; MOUTH MUCOSA; MOUTHWASH; MUCOSA INFLAMMATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0037278206     PISSN: 12329142     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Peterson D.E., Sonis S.T.: Oral complications of cancer chemotherapy: present status and future studies. Cancer Treat, Rep., 1982, 66(6), 1251-6.
2. Groopman J.E., Molina J.M., Scadden D.T.: Hematopoietic growth factors. Biology and clinical applications. N. Engl. J. Med., 1989, 321(21), 1449-59.
3. Antman K.S., Griffin J.D., Elias A., Socinski M.A., Ryan L., Cannistra S.A., Oette D., Whitley M., Frei E. 3rd, Schnipper L.E.: Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N. Engl. J. Med., 1988, 319(10), 593-8.
4. Chi K.H., Chen C.H., Chan W.K., Chow K.C., Chen S.Y., Yen S.H., Chao J.Y., Chang C.Y., Chen K.Y.: Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. J. Clin. Oncol., 1995, 13(10), 2620-8.
5. Cartee L., Petros W.P., Rosner G.L., Gilbert C., Moore S., Affronti M.L., Hoke J.A., Hussein A.M., Ross M., Rubin P., et al.: Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study. Cytokine, 1995, 7(5), 471-7.
6. Gabrilove J.L., Jakubowski A., Scher H., Sternberg C., Wong G., Grous J., Yagoda A., Fain K., Moore M.A., Clarkson B., et al.: Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N. Engl. J. Med., 1988, 318(22), 1414-22.
7. Lieschke G.J., Ramenghi U., O'Connor M.P., Sheridan W., Szer J., Morstyn G.: Studies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantation. Br. J. Haematol., 1992, 82(3), 589-95.
8. Dinarello C.A.: Interleukin-1 and interleukin-1 antagonism. Blood, 1991, 77(8), 1627-52.
9. Meropol N.J., Miller L.L., Korn E.L., Braitman L.E., MacDermott M.L., Schuchter L.M.: Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy. J. Natl. Cancer Inst., 1992, 84(15), 1201-3.
10. Bennett N.T., Schultz G.S.: Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am. J. Surg., 1993, 165(6), 728-37.
11. Wardley A.M., Scarffe J.H.: Role of granulocyte-macrophage colony-stimulating factor in chemotherapy-induced oral mucositis. J. Clin. Oncol., 1996, 14(5), 1741-3.